M
Myriad Genetics, Inc.
MYGN · NASDAQ · Healthcare · 286M
Closing price
$4.31
+2.62% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.1×
Enterprise value / EBITDAEV/EBITDA
-1.4×
Free cash flow yieldFCF yield
-6.4%
Return on equityROE
-99.4%
Operating margin
-8.2%
Net debt / EBITDAbalance-sheet strength
-0.2×
Interest coverage
-6.5×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.